Dear Members of the Englander Institute, I hope you were able to take some time off this summer and relax with friends and family members, and hopefully recharge for a productive autumn. As you’ll see below, members of the EIPM had a very...
Read more
August 2022 EIPM Director’s Memo Dear Members of the Englander Institute,Congratulations to Dr. Jedd Wolchok, a highly esteemed physician-scientist who pioneered immunotherapy for the treatment of melanoma, on becoming the new Director of...
Read more
July 2022 EIPM Director’s Memo Dear Members of the Englander Institute,We’ve had a number of visitors recently, including: Dr. Khalid Fakhro, Chief of Research and Director of Precision Medicine at Sidra Medicine in Qatar (right); Dr. ...
Read more
Weill Cornell Medicine and New York Genome Center researchers, in collaboration with Oxford Nanopore Technologies, have developed a new method to assess on a large scale the three-dimensional structure of the human genome, or how the genome...
Read more
November 2021 EIPM Director’s Memo Dear Members of the Englander Institute, It’s always a pleasure to share the important work and contributions of our colleagues, especially those who are just beginning their careers. Over the next...
Read more
Summer 2021 EIPM External Newsletter July 2021 Dear Friend of the Englander Institute for Precision Medicine, Welcome to our second quarterly newsletter of 2021! Thank you for signing-up on our website to receive this newsletter, we hope you...
Read more June 2021 EIPM Director’s Memo Dear Members of the Englander Institute, I hope you enjoy this month’s newsletter, which is packed with a remarkable number of news stories about the work of our colleagues, their awards, events and...
Read more
Dr. Marcin Imielinski, an assistant professor of pathology and laboratory medicine [and a Member of the Englander Institute for Precision Medicine], and Dr. Elena Piskounova, an assistant professor of cell biology in dermatology, both at Weill...
Read more
EIPM Researchers create rapid tests, analytics for COVID-19 Two distinct diagnostic tests, a host/pathogen RNA sequencing platform, and spatially resolved tissue mapping tools, were created by a multidisciplinary team of Weill Cornell...
Read more